Ph2 of INCB123667 in Platinum-Resistant Ovarian w/ Cyclin E1 Overexpression * GOG-3129
Phase II Clinical Trial
A Phase 2 Single-Arm Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 OverexpressionINCB123667-203
Participating Locations